Opsynvi (macitentan and tadalafil)

pCPA File Number: 21694

Negotiation Status:

Concluded without agreement

Indication(s):

Pulmonary Arterial Hypertension

Sponsor/Manufacturer:

Janssen Inc.

CDA-AMC Project Number:

SR0690-000

pCPA Engagement Letter Issued:

2022-02-16

Negotiation Process Concluded:

2022-05-09